Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, January 21 2017 5:15am ET - U.S. Markets Closed.
Industry Center - Drug Related Products
Industry Center > Drug Related Products > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Related Products News
Latest News
Tuesday, Jan 17, 2017
·CTD Holdings Receives FDA Fast Track Designation for Development of Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C
Marketwire - Tue Jan 17
Thursday, Jan 12, 2017
·Biotech and Healthcare Stocks Hit Hard by President Trump's Comments: Latest Reports on Endo International and Perrigo
- Thu Jan 12
Tuesday, Jan 10, 2017
·Perrigo Updates Segment Reporting Structure
PR Newswire - Tue Jan 10
Monday, Jan 9, 2017
·$50M deal: Bucks County firm selling Cold-Eeze brand
at - Mon Jan 9
·9 Questions with USANA Fitness Ambassador Erin Oprea
PR Newswire - Mon Jan 9
·ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM
Marketwire - Mon Jan 9
·ProPhase Labs, Inc. Announces Agreement to Sell Cold-EEZE(R) Brand
Marketwire - Mon Jan 9
Thursday, Dec 22, 2016
·Perrigo to Present at the J.P. Morgan Global Healthcare Conference
PR Newswire - Thu Dec 22
Wednesday, Dec 21, 2016
·Allergan's a Bargain That Could Pop 20%
at - Wed Dec 21
·CTD Holdings Files Clinical Trial Application with Italian Drug Agency to Continue Advancing Trappsol(R) Cyclo(TM) Drug Development Program to Treat Niemann-Pick Disease Type C
Marketwire - Wed Dec 21
Tuesday, Dec 20, 2016
·Perrigo Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette® White Ice Mint® Gum
PR Newswire - Tue Dec 20
Thursday, Dec 15, 2016
·CTD Holdings to Present at the WORLDSymposium on Compassionate Use of Cyclodextrins to Treat Niemann Pick Disease Type C and on Progress in US and EU Clinical Trials
Marketwire - Thu Dec 15
·USANA Selects Three New Vice Presidents
PR Newswire - Thu Dec 15
Monday, Dec 12, 2016
·4 Things That Practically Guarantee a Holiday Hangover: USANA's Dr. Dixon Tells You What NOT To Do
PR Newswire - Mon Dec 12
Thursday, Dec 8, 2016
·CTD Holdings to Present at the 2016 BioFlorida Annual Conference on Use of Cyclodextrins to Treat Niemann Pick Disease Type C
Marketwire - Thu Dec 8
·Perrigo Announces Portfolio Review Developments And Intention To Restructure Branded Consumer Healthcare's Belgium Business
PR Newswire - Thu Dec 8
·USANA Appoints New President And CIO
PR Newswire - Wed Dec 7
·USANA Appoints New President and CIO
Business Wire - Wed Dec 7
Tuesday, Dec 6, 2016
·Natasha Amin of Amexdrug Corporation (OTC PINK: AXRX) Announced Today the Release of Two Potent Topical Over-the-Counter Drugs for Arthritis Pain Relief, Nail & Skin Anti-Fungal and One Natural Nail Formula for Yellow, Discolored Nails
- Tue Dec 6
Thursday, Dec 1, 2016
·LifeSci Capital Initiates Coverage of CTD Holdings
- Thu Dec 1
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Related Products Headlines
More Finance RSS Feeds

Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?